DnB Asset Management
MEDP icon

DnB Asset Management’s Medpace MEDP Stock Holding History

DnB Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$632K Hold
1,193
– – ﹤0.01% 719
2026
Q1 		$573K Buy
+1,193
New +$611K ﹤0.01% 726

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

DnB Asset Management's MEDP Position: Q2 2026 in Review

DnB Asset Management held its Medpace (MEDP) position steady in Q2 2026 at 1,193 shares worth $632K. The position accounts for ﹤0.01% of the portfolio, ranked #719.

DnB Asset Management first reported a position in MEDP in Q1 2026 and has held it in 2 quarters since. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • DnB Asset Management held 1,193 shares of Medpace worth $632K as of Q2 2026.
  • DnB Asset Management left its Medpace share count unchanged in Q2 2026.
  • Medpace made up ﹤0.01% of DnB Asset Management's portfolio in Q2 2026, its #719 holding.
  • DnB Asset Management first reported a position in Medpace in Q1 2026 and has held it in 2 quarters since.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on DnB Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.